Navigation Links
ERBE Perseveres Yet Again in Opposition to Dr. Jerome Canady, and is Awarded More Than One Million Dollars
Date:3/7/2008

Innovative Family Firm Continues to protect its Intellectual Property that has been employed in Minimally Invasive Surgical Procedures for more than

one decade

MARIETTA, Ga., March 7 /PRNewswire/ -- In a much anticipated decision, Judge Joy Flowers Conti recently ruled that Dr. Jerome Canady of McKeesport, Pennsylvania is personally liable for expenses and attorneys' fees incurred by ERBE while defending against Dr. Canady's claim that ERBE had infringed a European patent in the U.K.

On March 21, 2005 Dr. Jerome Canady sued ERBE in the United Kingdom claiming that ERBE's Argon Plasma Coagulation (APC(TM)) probes infringed European Patent No. 0595967, a foreign counterpart to Canady's U.S. Patent No. 5,207,675. Before Canady filed the U.K. case, two American courts had already found that ERBE's probes did not infringe Canady's intellectual property rights in the U.S. ERBE denied that it infringed the U.K. patent and in December 2005, the British court agreed and ordered Dr. Canady to pay ERBE more than $1M. While Dr. Canady did not dispute that he owed the money to ERBE, Dr. Canady returned to the United States without paying ERBE.

In order to collect per court decree, on March 23, 2007, ERBE filed a complaint in the United States District Court for the Western District of Pennsylvania. Since Canady had no substantive defenses, almost immediately ERBE filed a motion for summary judgment that was granted by Judge Conti on February 19, 2008. Christian O. Erbe, Managing Director of ERBE Elektromedizin GmbH, a fifth generation family owned and operated business, expects Dr. Canady to abide by Judge Conti's order.

If necessary, ERBE will aggressively seek payment from Dr. Canady, with Mr. Erbe expressing his frustration in saying, "While it may take years for full restitution, ERBE will continue to use all legal means at its disposal including garnishment, seizure of property, and/or attachment to insure Dr. Jerome Canady's debt to ERBE is paid in full per court judgment." In a previous release dated May 12, 2006 referencing the UK court ruling, Mr. Erbe avowed that "I sincerely hope that Dr. Canady will abandon his attempts to use the legal process to shake down ERBE, so that we here at ERBE can get on with our business of providing medical practitioners worldwide with innovative, quality products that optimize patient outcomes, without the time-consuming distractions of baseless litigations."

About ERBE ELEKTROMEDIZIN GmbH and ERBE USA, Inc.

ERBE ELEKTROMEDIZIN GmbH is a 161-year innovator of interventional surgical devices and the holder of many European and US Patents. Its USA subsidiary, ERBE USA, Inc. is located in Marietta, GA. ERBE is the world's leading manufacturer and distributor of Electrosurgical Units and Argon Coagulators. The company has several inventions and patents related to its APC(TM) technology used in flexible endoscopes that explore the gastrointestinal tract (esophagus, stomach, colon and small bowel) and the tracheobronchial system (trachea, bronchi and lungs) without incisions of any type. APC(TM) technology is used to treat various bleeding diseases and lesions within the aforementioned anatomy. In the case of APC(TM), ERBE first introduced this innovation to the European markets in 1992 and the United States market in 1996.

Website: http://www.erbe-usa.com/

Website: http://www.erbe-med.com/


'/>"/>
SOURCE ERBE USA, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Annie Lennox Is Stepping Up and Singing Out in the 2008 Sing Campaign Against HIV/AIDS in South Africa and Around the World
2. Parker Waichman Alonso LLP Files Suit Against General Electric Company on Behalf of a Man Who Developed Nephrogenic Systemic Fibrosis (NSF) from Contrast Agent Omniscan
3. UNIFEM and Avon Announce Partnership to End Violence Against Women and Advance Womens Empowerment: Company Contribution Benefits UN Trust Fund
4. Task Force Recommends Against Screening for Chronic Obstructive Pulmonary Disease Using Spirometry
5. MSU research indicates testosterone could guard against eating disorders
6. Actor Rob Brown Rushes to Gain Ground Against Blood Cancer
7. Zebrafish provide useful screening tool for genes, drugs that protect against hearing loss
8. Dont Balance the Budget at the Expense of People With Disabilities ... Again
9. Jiffy Lube(R) Continues Drive Against Heart Disease with Maintenance Partners for Life Campaign
10. Closer Analysis Shows Consumer Groups Make Gains in Stem Cell Patent Challenges Against WARF; Appeal Still Planned Against Narrowed Claims
11. Weill Cornell team identifies potential new drug targets against hormone-dependent breast cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits ... terms of the latter, setting the bar too high can result in disappointment, perhaps ... slow progress toward their goal. , Research from PsychTests.com reveals that ...
(Date:6/24/2016)... ... 24, 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. ... the benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has ... , Sickle Cell Disease (SCD) is a disorder of the red blood cells, which ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Global law firm ... 2016 Legal Elite. The attorneys chosen by their peers for this recognition are considered ... Seven Greenberg Traurig Shareholders received special honors as members of this year’s Legal Elite ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway ... call for a minimum wage raise to $12 an hour by 2020 and then adjusting ... restore the lost value of the minimum wage, assure the wage floor does not erode ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
(Date:6/23/2016)... PARK RIDGE, Ill. and INDIANAPOLIS ... caliber of students receiving a Lilly Diabetes Tomorrow,s Leaders ... hands. The 2016 scholarship winners, announced today online at ... refused to let type 1 diabetes stand in the ... Lilly Diabetes has supported the Foundation,s scholarship program since ...
(Date:6/23/2016)... -- The vast majority of dialysis patients currently receive ... usually 3 times a week, with treatment times averaging ... equipment preparation and wait time.  This regimen can be ... who are elderly and frail.  Many elderly dialysis patients ... for some duration of time. Residents in ...
Breaking Medicine Technology: